Coronary artery disease and peripheral vascular disease in chronic kidney disease: An epidemiological perspective

Cardiology Clinics

Volumn 23, Issue 3, 2005, Pages 285-298

  Stack, Austin G ^a,b  

^a LETTERKENNY GENERAL HOSPITAL   (Ireland)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A INHIBITOR; ABCIXIMAB; ACETYLSALICYLIC ACID; CALCIUM CHANNEL BLOCKING AGENT; ENZYME INHIBITOR; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STREPTOKINASE; TIROFIBAN; UNCLASSIFIED DRUG;

ACUTE HEART FAILURE; AMPUTATION; ANGIOPLASTY; ARTERY BYPASS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DIALYSIS; DISEASE COURSE; DRUG EFFICACY; HEART PROTECTION; HUMAN; MORBIDITY; MORTALITY; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE;

CHRONIC DISEASE; CORONARY ARTERIOSCLEROSIS; COST OF ILLNESS; HUMANS; KIDNEY DISEASES; PERIPHERAL VASCULAR DISEASES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 23244462248     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2005.04.003     Document Type: Review

References (91)

1. A. Lindner, B. Charra, and D.J. Sherrard Accelerated atherosclerosis in prolonged maintenance hemodialysis N Engl J Med 290 1974 697 701
2. A.S. Levey, J.A. Beto, and B.E. Coronado Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to know? Where do we go from here? Am J Kidney Dis 32 1998 853 905
3. R.N. Foley, P.S. Parfrey, and M.J. Sarnak Clinical epidemiology of cardiovascular disease in chronic renal disease Am J Kidney Dis 32 1998 S112 S119
4. B.F. Culleton, M.G. Larson, and P.W. Wilson Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency Kidney Int 56 1999 2214 2219
5. J.F. Mann, H.C. Gerstein, and J. Pogue Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial Ann Intern Med 134 2001 629 636
6. G. Manjunath, H. Tighiouart, and H. Ibrahim Level of kidney function as a risk factor for atherosclerotic cardiovascular disease in the community J Am Coll Cardiol 41 2003 47 55
7. L.M. Ruilope, A. Salvetti, and K. Jamerson Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study J Am Soc Nephrol 12 2001 218 225
8. M.G. Shlipak, L.F. Fried, and C. Crump Cardiovascular disease risk status in elderly persons with renal insufficiency Kidney Int 62 2002 997 1004
9. S.E. Reis, M.B. Olson, and L. Fried Mild renal insufficiency is associated with angiographic coronary artery disease in women Circulation 105 2002 2826 2829
10. G. Manjunath, H. Tighiouart, and J. Coresh Level of kidney function as a risk factor for cardiovascular outcomes in the elderly Kidney Int 63 2003 1121 1129
11. P.J. Friedman Serum creatinine: an independent predictor of survival after stroke J Intern Med 229 1991 175 179
12. P.A. McCullough, S.S. Soman, and S.S. Shah Risks associated with renal dysfunction in patients in the coronary care unit J Am Coll Cardiol 36 2000 679 684
13. A.S. Levey, J. Coresh, E. Balk for the National Kidney Foundation National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification Ann Intern Med 139 2002 137 147
14. US Renal Data System Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients Am J Kidney Dis 20 1992 32 38
15. A.P.S. Disney ANZDATA Report 1998. Australia and New Zealand Dialysis and Transplantation Registry 1999 Australia and New Zealand Dialysis and Transplant Registry Adelaide (Australia)
16. A.G. Stack, and W.E. Bloembergen Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study J Am Soc Nephrol 12 2000 1516 1523
17. J.C. Longnecker, J. Coresh, and N.R. Powe Traditional cardiovascular disease risk factors in dialysis patients compared with the general population. The CHOICE Study J Am Soc Nephrol 13 2002 1918 1927
18. Canadian Organ Replacement Register 1998 annual report 1998 Canadian Institute for Health Information Don Mills (Ontario, Canada)
19. United States Renal Data System Patient characteristics at the start of ESRD: data from the HCFA Medical Evidence Form Am J Kidney Dis 34 1999 S63 S73
20. F. Gradaus, K. Ivens, and A.J. Peters Angiographic progression of coronary artery disease in patients with end-stage renal disease Nephrol Dial Transplant 16 2001 1198 1202
21. P. Raggi, A. Boulay, and S. Chasan-Taber Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39 2002 695 701
22. A.M. O'Hare, C.Y. Hsu, and P. Bacchetti Peripheral vascular disease risk factors among patients undergoing hemodialysis J Am Soc Nephrol 13 2002 497 503
23. Y. Leskinen, J.P. Salenius, and T. Lehtimaki The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics Am J Kidney Dis 40 2002 472 479
24. D.N. Reddan, R.J. Marcus, and W.F. Owen Jr. Long-term outcomes of revascularization for peripheral vascular disease in end-stage renal disease patients Am J Kidney Dis 38 2001 57 63
25. A.K. Cheung, M.J. Sarnak, and G. Yan Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients Kidney Int 58 2000 353 362
26. J.C. Longenecker, J. Coresh, and N.R. Powe Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study J Am Soc Nephrol 13 2002 1918 1927
27. M.J. Sarnak, B.E. Coronado, and T. Greene Cardiovascular disease risk factors in chronic renal insufficiency Clin Nephrol 57 2002 327 335
28. P.S. Parfrey, R.N. Foley, and J.D. Harnett Outcome and risk factors of ischemic heart disease in chronic uremia Kidney Int 49 1996 1428 1434
29. K. Kalantar-Zadeh, G. Block, and M.H. Humphreys Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients Kidney Int 63 2003 793 808
30. E.G. Lowrie, and N.L. Lew Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities Am J Kidney Dis 15 1990 458 482
31. S.K. Ganesh, T. Hulbert-Shearon, and K. Eagle Mortality differences by treatment modality among incident ESRD patients with and without coronary artery disease J Am Soc Nephrol 14 2003 415 424
32. A.G. Stack, D.A. Molony, and S.N. Rahman Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States Kidney Int 64 2003 1071 1079
33. E. Ejerblad, M.C. Fored, and P. Lindblad Association between smoking and chronic renal failure in a nationwide population-based case-control study J Am Soc Nephrol 15 2004 2178 2185
34. M.K. Haroun, B.G. Jaar, and S.C. Hoffman Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington county, Maryland J Am Soc Nephrol 14 2003 2934 2941
35. S.J. Pinto-Sietsma, J. Mulder, and W.M. Janssen Smoking is related to albuminuria and abnormal renal function in nondiabetic persons Ann Intern Med 133 2000 585 591
36. F. Madore Uremia-related metabolic cardiac risk factors in chronic kidney disease Semin Dial 16 2003 148 156
37. P. Muntner, L.L. Hamm, and J.W. Kusek The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease Ann Intern Med 140 2004 9 17
38. S.M. Haffner, K.K. Gruber, and G. Aldrete Jr. Increased lipoprotein (a) concentrations in chronic renal failure J Am Soc Nephrol 3 1992 1156 1162
39. P. Stenvinkel, O. Heimburger, and C.H. Tuck Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure Kidney Int 53 1998 1336 1342
40. A.G. Bostom, D. Shemin, and K.L. Lapane Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study Atherosclerosis 125 1996 91 101
41. M.G. Shlipak, L.F. Fried, and C. Crump Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency Circulation 107 2003 87 92
42. B.P. Oberg, E. McMenamin, and F.L. Lucas Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease Kidney Int 65 2004 1009 1016
43. M. Koch, B. Kutkuhn, and E. Trenkwalder Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein (a) phenotypes predict coronary artery disease in hemodialysis patients J Am Soc Nephrol 8 1997 1889 1898
44. S.H. Mudd, F. Skovby, and H.L. Levy The natural history of homocystinuria due to cystathionine betasynthase deficiency Am J Hum Genet 37 1985 1 31
45. G.S. Omenn, S.A. Beresford, and A.G. Motulsky Preventing coronary heart disease: B vitamins and homocysteine Circulation 97 1998 421 424
46. C.J. Boushey, S.A. Beresford, and G.S. Omenn A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes JAMA 274 1995 1049 1057
47. S.A. Beresford, and C.J. Boushey Homocysteine, folic acid, and cardiovascular disease risk A. Bendich R.J. Deckelbaum Preventive nutrition: the comprehensive guide for health professionals 1997 Humana Press Totowa (NJ) 193 224
48. A.G. Bostom, J. Selhub, and P.F. Jacques Power shortage: clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour Ann Intern Med 135 2001 133 137
49. A. Moustapha, A. Naso, and M. Nahlawi Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease Circulation 97 1998 138 141
50. A.G. Bostom, D. Shemin, and P. Verhoef Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients: a prospective study Arterioscler Thromb Vasc Biol 17 1997 2554 2558
51. P. Jungers, P. Chauveau, and O. Bandin Hyperhomocysteinemia is associated with atherosclerotic occlusive arterial accidents in predialysis chronic renal failure patients Miner Electrolyte Metab 23 1997 170 173
52. Z.A. Massy, B. Chadefaux-Vekemans, and A. Chevalier Hyperhomocysteinemia: a significant risk factor for cardiovascular disease in renal transplant recipients Nephrol Dial Transplant 9 1994 1103 1108
53. J.F. Belch Metabolic, endocrine and hemodynamic risk factors in the patient with peripheral arterial disease Diabetes Obes Metab 4 2002 S2 S7
54. J.F. Price, P.I. Mowbray, and A.J. Lee Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease Edinburgh Artery Study. Eur Heart J 20 1999 344 353
55. A.J. Lee, A.S. MacGregor, and C.M. Hau The role of haematological factors in diabetic peripheral arterial disease: the Edinburgh artery study British Journal of Haematology 105 3 1999 648 654
56. J.F. Price, A.J. Lee, and F.G. Fowkes Hyperinsulinaemia: a risk factor for peripheral arterial disease in the non-diabetic general population J Cardiovasc Risk 3 1996 501 505
57. P.M. Ridker, M.J. Stampfer, and N. Rifai Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a), and standard cholesterol screening as predictors of peripheral arterial disease JAMA 285 2001 2481 2485
58. A.M. O'Hare, P. Bacchetti, and M. Segal Dialysis Morbidity and Mortality Study Waves. Factors associated with future amputation among patients undergoing hemodialysis: results from the Dialysis Morbidity and Mortality Study Waves 3 and 4 Am J Kidney Dis 41 2003 162 170
59. A.M. O'Hare, E. Vittinghoff, and J. Hsia Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the Heart and Estrogen/progestin Replacement Study (HERS) J Am Soc Nephrol 15 2004 1046 1051
60. P.W. Eggers, D. Gohdes, and J. Pugh Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population Kidney Int 56 1999 1524 1533
61. L.W. Fleming, C.P. Stewart, and I.S. Henderson Limb amputation on renal replacement therapy Prosthet Orthot Int 24 2000 7 12
62. N.M. McGrath, and B.A. Curran Recent commencement of dialysis is a risk factor for lower-extremity amputation in a high-risk diabetic population Diabetes Care 23 2000 432 433
63. S. Morbach, C. Quante, and H.R. Ochs Increased risk of lower-extremity amputation among Caucasian diabetic patients on dialysis Diabetes Care 24 2001 1689 1690
64. B.G. Jaar, B.C. Astor, and J.S. Berns Predictors of amputation and survival following lower extremity revascularization in hemodialysis patients Kidney Int 65 2004 613 620
65. G.A. Block, T.E. Hulbert-Shearon, and N.W. Levin Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study Am J Kidney Dis 31 1998 601 617
66. 4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients J Am Soc Nephrol 12 2001 2131 2138
67. G.M. Chertow, S.K. Burke, and P. Raggi Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients Kidney Int 62 2002 245 252
68. J.S. Fernandez, B.T. Sadaniantz, and A. Sadaniantz Review of antithrombotic agents used for acute coronary syndromes in renal patients Am J Kidney Dis 42 2003 446 455
69. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2 Lancet 2 1988 349 360
70. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) A factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction Lancet 336 1990 65 71
71. International Study Group In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomized between alteplase and streptokinase with or without heparin Lancet 336 1990 71 75
72. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group A randomized comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction Lancet 339 1993 753 770
73. GUSTO Investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682
74. J.L. Januzzi, S.M. Snapinn, and P.M. DiBattiste Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial Circulation 105 2002 2361 2366
75. D.N. Reddan, J.C. O'Shea, and I.J. Sarembock Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial) Am J Cardiol 91 2003 17 21
76. J. Al Suwaidi, D.N. Reddan, and K. Williams GUSTO-IIb, GUSTO-III, PURSUIT. Global Use of Strategies to Open Occluded Coronary Arteries. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. PARAGON-A Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes Circulation 106 2002 974 980
77. P.A. Gum, M. Thamilarasan, and J. Watanabe Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: a propensity analysis JAMA 286 2001 1187 1194
78. F.C. Trespalacios, A.J. Taylor, and L.Y. Agodoa Incident acute coronary syndromes in chronic dialysis patients in the United States Kidney Int 62 2002 1799 1805
79. P.A. McCullough, K.R. Sandberg, and S. Borzak Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease Am Heart J 144 2 2002 226 232
80. M. Tonelli, L. Moye, and F.M. Sacks Cholesterol and Recurrent Events (CARE) Trial Investigators. Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency Ann Intern Med 138 2003 98 104
81. B. Kestenbaum, D.L. Gillen, and D.J. Sherrard Calcium channel blocker use and mortality among patients with end-stage renal disease Kidney Int 61 2002 2157 2164
82. S.L. Seliger, N.S. Weiss, and D.L. Gillen HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients Kidney Int 61 2002 297 304
83. A. Ishani, C.A. Herzog, and A.J. Collins Cardiac medications and their association with cardiovascular events in incident dialysis patients: cause or effect? Kidney Int 65 2004 1017 1025
84. L.M. Reusser, L.A. Osborn, and H.J. White Increased morbidity after coronary angioplasty in patients on chronic hemodialysis Am J Cardiol 73 1994 965 967
85. S.P. Marso, L.W. Gimple, and J.T. Philbrick Effectiveness of percutaneous coronary interventions to prevent recurrent coronary events in patients on chronic hemodialysis Am J Cardiol 82 1998 378 380
86. S.A. Simsir, D. Kohlman-Trigoboff, and R. Flood A comparison of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in patients on hemodialysis Cardiovasc Surg 6 1998 500 505
87. C.A. Herzog, J.Z. Ma, and A.J. Collins Long-term outcome of dialysis patients in the United States with coronary revascularization procedures Kidney Int 56 1999 324 332
88. M. Agirbasli, W.S. Weintraub, and G.L. Chang Outcome of coronary revascularization in patients on renal dialysis Am J Cardiol 86 2000 395 399
89. L. Szczech, D. Reddan, and W. Owen Jr. Differential survival after coronary revascularization procedures among patients with renal insufficiency Kidney Int 60 2001 292 299
90. C.A. Herzog, J.Z. Ma, and A.J. Collins Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes Circulation 106 2002 2207 2211
91. D.N. Reddan, L.A. Szczech, and R.H. Tuttle Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease J Am Soc Nephrol 14 2003 2373 2380